Hee-Beom Yang, Soo Min Ahn, Min Jeng Cho, Yong-Hoon Cho, Soo Jin Na Choi, Yoon Mi Choi, Jae Hee Chung, Seok Joo Han, In Geol Ho, Jeong Hong, Kyong Ihn, Yeon Jun Jeong, Eunyoung Jung, Dae Youn Kim, Hae-Young Kim, Ki Hoon Kim, Seong Chul Kim, Soo-Hong Kim, Eun-Jung Koo, Hyun Hee Kwon, Yong Jae Kwon, Nam-Hyuk Lee, Ju Yeon Lee, Sanghoon Lee, Jung-Man Namgoong, Chaeyoun Oh, Jung-Tak Oh, Jin Young Park, Junbeom Park, Jeong-Meen Seo, Jae Ho Shin, Hyun Beak Shin, Joohyun Sim, Jiyoung Sul, Joon Kee Youn, Hyun-Young Kim
Adv Pediatr Surg 2025;31(2):66-76. Published online November 25, 2025
Purpose To report a nationwide survey on neuroblastoma conducted by the Korean Association of Pediatric Surgeons (KAPS) in 2020.
Methods The clinical data of pediatric patients diagnosed with and treated for neuroblastoma from 2005 to 2019 in 19 hospitals of KAPS members were collected. Survival and prognostic factor analyses were performed using the log rank test and Cox proportional hazard analysis. A p-value <0.05 was considered significant.
Results A total of 669 patients with neuroblastoma were registered for the study. The results were presented and discussed at the 36th annual meeting of the KAPS, which was held in Seoul on August 21, 2020.
Conclusion This study provides information on patient demographics, prognostic outcomes, and comprehensive treatment outcomes for neuroblastoma. The study is expected to be an important reference for improving pediatric surgeons’ understanding and treatment of neuroblastoma.
First
Prev
